ZVRA
Conviction 37HealthcareScan · Thu, Sep 24, 2026Zevra Therapeutics, Inc. (ZVRA) closed at $11.26 (-0.57%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 41, RS Rating 77, -23.7% from its 52-week high, +34.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ZVRA
Insider activity
SEC Form 4 transactions in ZVRA · open-market 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Thompson Rahsaan Chief Legal & Compliance · Common Stock · 2026-08-14 | Sell | 42.67K | $475K | 2026-08-14 | 2026-08-17 |
Watton Corey Michael Director · Common Stock · 2026-08-10 | Exercise | 12.3K | $61K | 2026-08-10 | 2026-08-12 |
Watton Corey Michael Director · Common Stock · 2026-08-10 | Sell | 12.3K | $138K | 2026-08-10 | 2026-08-12 |
Watton Corey Michael Director · Stock Option (right to buy) · 2026-08-10 | Exercise | 12.3K | — | 2026-08-10 | 2026-08-12 |
FAVORITO TAMARA A Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
Anderson Thomas Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
Calder Douglas W Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
Secor Alicia Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
Shih Alvin Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
Watton Corey Michael Director · Stock Option (right to buy) · 2026-06-04 | Grant | 30K | — | 2026-06-04 | 2026-06-18 |
SEC filings
EDGAR filings in ZVRA · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.